Association of serum uric acid with cardiovascular disease in rheumatoid arthritis

Rheumatology

Volumn 46, Issue 9, 2007, Pages 1466-1470

  Panoulas, V F ^a,b   Milionis, H J ^b   Douglas, K M J ^a   Nightingale, P ^c   Kita, M D ^a   Klocke, R ^a   Elisaf, M S ^b   Kitas, G D ^a  

^a RUSSELLS HALL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF IOANNINA   (Greece)

^c UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Association; Cardiovascular disease; Rheumatoid arthritis; Uric acid

Indexed keywords

ANTIHYPERTENSIVE AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METHOTREXATE; URIC ACID;

ADULT; AGED; ARTICLE; BIVARIATE ANALYSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HIGH RISK PATIENT; HUMAN; HYPERURICEMIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; URIC ACID BLOOD LEVEL;

AGED; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; RISK FACTORS; SEVERITY OF ILLNESS INDEX; URIC ACID;

EID: 34548252956     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem159     Document Type: Article

References (52)

1. Wolfe F, Freundlich B, Straus V. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 2003;30:36-40.
2. Solomon D, Karlson E, Rimm E, Cannuscio C, Mandl M. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003; 107:1303-7.
3. del Rincon I, Williams K, Stem MP, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by classical risk factors. Arthritis Rheum 2001;44:2737-45.
4. Maradit-Kremers H, Crowson CS, Nicola PJ et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: A population-based cohort study. Arthritis Rheum 2005;52:402-11.
5. Banks MJ, Pace AV, Kitas GD. Acute coronary syndromes present atypically and recur more frequently in rheumatoid arthritis than matched controls [abstract]. Arthritis Rheum 2001;44:S53.
6. Sheifer SE, Manolio TA, Gersh BJ. Unrecognized myocardial infarction. Ann Intern Med 2001;135:801-11.
7. Erb N, Pace AV, Douglas KMJ, Banks MJ, Kitas GD. Risk assessment for coronary heart disease in rheumatoid arthritis and osteoarthritis. Scand J Rheumatol 2004;33:293-9.
8. Criswell LA, Medino LA, Cerhan JR et al. Cigarette smoking and the risk of rheumatoid arthritis amongst postmenopausal women: Results from the Iowa Women's Health Study. American J Med 2006;112:465-71.
9. Symmons DPM, Bankhead C, Harrison BJ, Brennan P, Barrett EM, Scott DG. Blood transfusion, smoking and obesity as risk factors for development of rheumatoid arthritis; results from a primary care based incident case-control study in Norfolk, England. Arthritis Rheum 1997;40:1955-61.
10. Situnayake RD, Kitas G. Dyslipidaemia and rheumatoid arthritis. Ann Rheum Dis 1997;56:341-2.
11. Dessein PH, Joffe BI, Stanwix A, Botha AS, Moomal Z. The acute phase response does not fully predict the presence of insulin resistance and dyslipidaermia in inflammatory arthritis. J Rheumatol 2002;29:462-6.
12. Dessein PH, Joffe BI. When is a patient with rheumatoid arthritis at risk for cardiovascular disease? J Rheumatol 2006;33:201-3.
13. Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: A reaction to atherosclerosis? Atherosclerosis 2000; 148:131-9.
14. Johnson RJ, Kang DH, Feig D et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertens 2003;41:1183-90.
15. Fang J, Alderman MH. Serum uric acid and cardiovascular mortality the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000;283:2404-10.
16. Brand FN, McGee DL, Kennel WB, Stokes Jill, Castalli WP. Hyperuricemia as a risk factor of coronary heart disease: The Framingham Study. Am J Epidemiol 1985;121:11-18.
17. Atdjian M, Fernandez-Madrid F. Coexistence of chronic tophaceous gout and rheumatoid arthritis. J Rheumatol 1981;8:989-92.
18. Modesto dos Santos V, Cezar BF, Barbosa ER, Carvalho FR. Coexistent gout and rheumatoid arthritis: A case report. Br J Hosp Med (Lond) 2005;66:704-5.
19. Dessain PH, Joffe BI, Veller MG et al. Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis. J Rheumatol 2005;32:435-42.
20. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
21. Prevoo ML, van't Hof MA, Kuper HH, van Leeuwen MA, van do Putte LB, van Riel PL. Modified disease activity soores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patents with rheumatoid arthritis. Arthrit Rheum 1995;38:44-8.
22. Kinvan A Reeback JS. Stanford heafth assessment questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 1986;25:206-9.
23. Williams B, Poulter NR, Brown MJ et al. Guidelines for management of hypertension: Report of the fourth working party of the British Hypertension Society, 2004-BHS IV. J Hum Hypertens 2004;18:139-85.
24. National Collaborating Centre for Chronic Conditions. Hypertension: management of hypertension in adults in primary care: Partial update. London: Royal College of Physicians, 2006.
25. Heyden S, Bartel AG, Tabesh E et al. Angina pectoris and the Rose questionnaire. Arch Intern Med 1971;128:961-4.
26. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: A new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: Insulin resistance and bets-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
28. Katz A, Nambi SS, Mather K et al. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-10.
29. Wannamethee SG, Shaper AG, Whincup PH. Serum urate and the risk of major coronary heart disease events. Heart 1997;78:147-53.
30. Sakata K, Hashimoto T, Ueshima H, Okayama A. Absence of an association between serum uric acid and mortality from cardiovascular disease: NIPPON DATA 80, 1980-1994. National integrated projects for prospective observation of non-communicable diseases and its trend in the aged. Eur J Epidemiol 2001;17:461-8.
31. Persky VW, Dyer AR, Idris-Soven E et al. Uric acid: A risk factor for coronary heart disease? Circulation 1979;59:969-77.
32. Culleton BF, Larson MG, Kennel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study. Ann Intern Med 1999;131:7-13.
33. Freedman DS, Williamson DF, Gunter EW, Byers T. Relation of serum uric acid to mortality and ischemic heart disease. The NHANES 1 epidemiologic follow-up study. Am J Epidemiol 1995;141:637-44.
34. Lehto S, Niskanen L, Ronnemaa T, Laakso M. Serum uric acid is a strong predictor of stroke in patients with non-insulin-dependent diabetes mellitus. Stroke 1998;29:635-9.
35. Alderman MH, Cohen H, Madhavan S, Kivlighn S, Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertens 1999;34:144-50.
36. McEntegart A, Capell HA, Creran D, Rumley A, Woodward M, Lowe GD. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatol 2001;40:640-4.
37. Mazzali M, Hughes J, Kim YG et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertens 2001;38:1101-6.
38. Alper AB,Jr, Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL. Childhood uric acid predicts adult blood pressure: The Bogalusa Heart Study. Hypertens 2005;45:34-8.
39. Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Karnel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertens 2005;45:28-33.
40. Feig DI. Uric acid and hypertension in adolescents. Semin Nephrol 2005;25:32-8.
41. Karvounaris SA, Sidiropoulos PI, Papadakis JA et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity a retrospective, cross-sectional, controlled, study. Ann Rheum Dis 2007;66:28-33.
42. Muscalli E, Natali A, Bianchi S et al. Effect of insulin on renal sodium and uric acid handling in essential hypertension. Am J Hypertens 1996;9:746-52.
43. Short RA, Johnson RJ, Tuttle KR. Uric acid, microalbuminuria and cardiovascular events in high-risk patients. Am J Nephrol. 2005;25:36-44
44. MacMahon S, Peto R, Cutler J et al. Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure; prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-74.
45. Khosla UM, Zharikov S, Finch JL et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005;67:1739-42.
46. Schmieder RE. Endothelial dysfunction: How can one intervene at the beginning of the cardiovascular continuum? J Hypertens Suppl 2006;24:S31-5.
47. Kanellis J, Watanabe S, Li JH, Kang DH et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertens 2003;41:1287-93.
48. Kang DH, Nakagawa T, Fang L et al. A role for uric acid in the progression of renal disease. J Am Soc Nephrol 2002;13:2888-97.
49. Gu L, Okada Y, Clinton SK et al. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mal Cell 1998;2:275-81.
50. Kang DH, Seoh Y, Yoon K-I., A possible link between hyperuricemia and systemic inflammatory reaction as a mechanism of endothelial dysfunction in chronic renal failure. American Society of Nephrology 35th Annual Meeting and Scientific Exposition 2002;13:466A.
51. Kofler S, Nickel T, Weis M. Role of cytokines in cardiovascular diseases: A focus on endothelial responses to inflammation. Clin Sci 2005;108:205-13.
52. Danesh J, Wheeler JG, Hirschfield GM et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004;350:1387-97.